
    
      Purpose: pharmacokinetic interactions and safety of AD-2111 and AD-2112 in healthy adult
      volunteers Condition or disease : Pain Intervention/treatment Drug : AD-2111(Celecoxib
      200mg), AD-2112(Tramadol 150mg) Phase : Phase 1
    
  